Sex: U
Vaccine: COVID19, FLUX, VARZOS
Symptoms: Atrial flutter, Dyspnoea, Palpitations, Transient ischaemic attack
Clinical narrative: Atrial Flutter; possible transient ischemic attack; heart pounding; shortness of breath walking stairs; This serious case was reported by a consumer via other manufacturer and described the occurrence of atrial flutter in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included INFLUENZA VACCINE for prophylaxis and TOZINAMERAN (COMIRNATY) (batch number HG2282) for prophylaxis.   Previously administered products included Pfizer BioNTech COVID-19 vaccine (received 1st dose of pfizer biontech in left arm of batch number ER8730), Pfizer BioNTech COVID-19 vaccine (received 2nd dose of pfizer biontech in left arm of batch number EW0161), Pfizer BioNTech COVID-19 vaccine (received 3rd dose of pfizer biontech in left arm of batch number 320308), Pfizer BioNTech COVID-19 vaccine (received 4th dose of pfizer biontech in left arm of batch number FJ4989) and Pfizer BioNTech COVID-19 vaccine (received 5th dose of pfizer biontech in left arm of unknown batch number ). Concurrent medical conditions included penicillin allergy (had possibly penicillin allergy). Concomitant products included levothyroxine sodium (Levothyroxine), atorvastatin and tadalafil.   On 29-SEP-2023, the patient received the 1st dose of Shingrix (left arm) and the 1st dose of INFLUENZA VACCINE (left arm). On 29-SEP-2023 10:00, the patient received the 6th dose of COMIRNATY (left arm). On 01-OCT-2023, 2 days after receiving Shingrix and INFLUENZA VACCINE, the patient experienced heart pounding (Verbatim: heart pounding) (serious criteria hospitalization) and shortness of breath (Verbatim: shortness of breath walking stairs) (serious criteria hospitalization). On an unknown date, the patient experienced atrial flutter (Verbatim: Atrial Flutter) (serious criteria hospitalization) and transient ischemic attack (Verbatim: possible transient ischemic attack) (serious criteria hospitalization and GSK medically significant). The outcome of the atrial flutter and transient ischemic attack were not reported and the outcome of the heart pounding and shortness of breath were resolving.   It was unknown if the reporter considered the atrial flutter, transient ischemic attack, heart pounding and shortness of breath to be related to Shingrix.     It was unknown if the company considered the atrial flutter, transient ischemic attack, heart pounding and shortness of breath to be related to Shingrix.   Additional Information: GSK Receipt Date: 22-DEC-2023 The patient received medication within 2 weeks of vaccination were buproprion, levothyroxine, atorvastatin, tadalafil. The reporter reported that the patient received shingrix vaccine, influenza vaccine and pfizer comirnaty on the same day in left arm. The reporter reported that month of October and November the patient had shortness of breath walking stairs, significant heart pounding in chest. The patient ended up in the emergency room on the evening of 17th November 2023 and was in the hospital until 21th November 2023  The patient was diagnosed with atrial flutter and possible transient ischemic attack. On 30th November 2023, the patient had a cardioversion. Since the vaccination the patient had not been tested for covid-19. It was unknown if the reporter considered the heart pounding, shortness of breath and atrial flutter to be related to pfizer comirnaty and influenza vaccine.